Literature DB >> 4825098

Systemic arterial disease and chronic arsenicism in infants.

H G Rosenberg.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4825098

Source DB:  PubMed          Journal:  Arch Pathol        ISSN： 0363-0153


× No keyword cloud information.
  31 in total

1.  Urine arsenic concentration and obstructive pulmonary disease in the U.S. population.

Authors:  Eric D Amster; Jang Ik Cho; David Christiani
Journal:  J Toxicol Environ Health A       Date:  2011

Review 2.  Arsenic exposure in Latin America: biomarkers, risk assessments and related health effects.

Authors:  Tyler R McClintock; Yu Chen; Jochen Bundschuh; John T Oliver; Julio Navoni; Valentina Olmos; Edda Villaamil Lepori; Habibul Ahsan; Faruque Parvez
Journal:  Sci Total Environ       Date:  2011-11-26       Impact factor: 7.963

3.  Effects of chronic exposure to arsenate on the cardiovascular function of rats.

Authors:  M Carmignani; P Boscolo; A Iannaccone
Journal:  Br J Ind Med       Date:  1983-08

Review 4.  Impact of prenatal arsenic exposure on chronic adult diseases.

Authors:  Jamie L Young; Lu Cai; J Christopher States
Journal:  Syst Biol Reprod Med       Date:  2018-06-06       Impact factor: 3.061

Review 5.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

6.  Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study.

Authors:  Farrah J Mateen; Maria Grau-Perez; Jonathan S Pollak; Katherine A Moon; Barbara V Howard; Jason G Umans; Lyle G Best; Kevin A Francesconi; Walter Goessler; Ciprian Crainiceanu; Eliseo Guallar; Richard B Devereux; Mary J Roman; Ana Navas-Acien
Journal:  Environ Res       Date:  2017-05-26       Impact factor: 6.498

7.  Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.

Authors:  Akhilesh Kaushal; Hongmei Zhang; Wilfried J J Karmaus; Todd M Everson; Carmen J Marsit; Margaret R Karagas; Shih-Fen Tsai; Hui-Ju Wen; Shu-Li Wang
Journal:  Environ Health       Date:  2017-05-30       Impact factor: 5.984

8.  In utero and postnatal exposure to arsenic alters pulmonary structure and function.

Authors:  R Clark Lantz; Binh Chau; Priyanka Sarihan; Mark L Witten; Vadim I Pivniouk; Guan Jie Chen
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-27       Impact factor: 4.219

9.  Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice.

Authors:  Sanjay Srivastava; Elena N Vladykovskaya; Petra Haberzettl; Srinivas D Sithu; Stanley E D'Souza; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-12       Impact factor: 4.219

10.  In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.

Authors:  M A Alam; M A Awal; N Subhan; M Mostofa
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.